October 13, 2025
Holmes Chapel, UK, 13 October 2025 — Bespak, the specialist inhalation contract development and manufacturing organisation (CDMO), has appointed Tarik Hage as Chief Commercial Officer.
Since its launch just over one year ago, Bespak has built strong momentum in the inhaled and nasal drug delivery market. The appointment of Tarik Hage as Chief Commercial Officer, with over 20 years of experience in commercial strategy, business development, and customer engagement, will further strengthen the company’s leadership team.
Tarik brings a strong track record of building global partnerships and delivering cross functional strategic alignment to foster commercial excellence. Most recently, he served as Vice President for Commercial & Business Development at GKN Automotive, where he built a reputation for forging strong customer relationships, navigating complex challenges, and leading teams with energy and purpose to meet the ever-changing needs of customers in a demanding sector. He holds a bachelor’s degree in engineering from Universidade Presbiteriana Mackenzie and an MBA in marketing from UNIMEP (Universidade Metodista de Piracicaba), and his unique perspectives from the automotive industry will provide new insights and opportunities for Bespak and its customers to secure the next wave of growth.
“I’m confident Tarik will be a fantastic addition to the team, enhance our customer relationships and help us deliver even greater impact across the industry,” said Chris Hirst, Bespak CEO. “His strategic mindset and deep understanding of customer needs will strengthen our position as a trusted partner—delivering real value to our customers at every stage.”
Bespak is committed to leading the industry’s transition to low Global Warming Potential (GWP) propellants in pressurised Metered Dose Inhalers (pMDIs) and to providing exceptional solutions across inhaled and nasal drug delivery. Tarik’s deep understanding of technologically-driven and highly regulated markets will be pivotal in accelerating these ambitions.
For further information and interview opportunities with Bespak, please contact:
Sarah Guinane at Notch Communications
About Bespak:
Bespak is a specialist global contract development and manufacturing organisation (CDMO) solely focused on the inhaled and nasal drug delivery industry. It develops and manufactures inhaled and nasal drug products, drug delivery devices and components for the global pharmaceutical market. Headquartered in Holmes Chapel, UK, Bespak provides a specialist, fully integrated service to support customers from early-stage feasibility, analytical and formulation, product development and clinical supply, through to full-scale cGMP batch production.
More information: https://bespak.com
